scorecardresearch
Tuesday, August 12, 2025
TopicCovid drug

Topic: Covid drug

Dr Reddy’s announces commercial launch of Covid drug 2-DG, to cost Rs 990/sachet

The drug was developed by DRDO in collaboration with Dr Reddy's and granted emergency use approval on 1 May. It will be supplied to major govt and private hospitals across India.

Why Covid drug Ivermectin remains popular despite warnings & lack of evidence on efficacy

University of Oxford has launched a large study to investigate the use of Ivermectin for Covid-19 treatment, amid guidelines across the world, warning against the use of the drug. 

Most drugs given to adult Covid patients not recommended for children, govt says

Drugs such as ivermectin, hydroxychloroquine, favipiravir and antibiotics like doxycycline & azithromycin have not been tested on kids for Covid treatment, said the health ministry.

Biophore applies to DCGI for emergency use approval of anti-Covid drug Aviptadil

Company CEO Jagadeesh Rangisetty said Aviptadil is a promising treatment option especially in severe hospitalised cases of Covid where trials have shown a high recovery percentage.

Could a simple pill beat Covid-19? Pfizer is giving it a go

Where most antiviral agents target the inflammatory and immune response resulting from Covid, Pfizer’s pill directly targets the virus itself.

Mukesh Ambani’s RIL is working to produce new Covid drug, cheaper testing kits

Reliance is exploring use of a tapeworm drug, Niclosamide, as a cure for Covid & its diagnostic kits — R-Green & R-Green Pro — have been approved by ICMR.

On Camera

The speech PM Modi should deliver this Independence Day

For the last 11 years, Nehru has been constantly blocking my efforts and causing the fiascos that are my many yojanas and abhiyans. He is the reason most of my initiatives turn into disasters.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

Can’t restrict ‘extent of induction’—why SC struck down gender quotas in Army’s JAG recruitment

New Delhi: The Supreme Court has ruled that the Indian Army cannot cap the number of women in its Judge Advocate General (JAG) branch...

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.